ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Streamlining A Complex Phase 2 RTSM Build

  A complex Phase 2 trial with blinded and open-label paths needed its randomization system fast. See how smart defaults cut sponsor review work and protected the first-patient date.

• Internal Validation Study: Ultra-Low Temperature Labels

  Clinical trial vials held at ultra-low temperatures need labels that stay put. Three label formats, applied under dry ice conditions, were compared for qualification.

• QP Certification Of Investigational Medicinal Products In The EU And UK

  Personal legal responsibility, post-Brexit certification rules, and a three-part documentation review shape how investigational batches reach patients in the EU and UK, and how sponsors work with their certifying QP.

• Accelerating A Complex Global Cardiovascular Outcomes Trial Via Coordinated Execution

  Coordinating CRO, clinical supply, and central lab activities from the start shaped how a 1,500-site, 35-country cardiovascular outcomes trial moved ahead of plan on activation and enrollment.

• Turning Rapid Study Start-Up Into Enrollment Momentum

  A large Phase III ATTR-CM outcomes trial spanning 37 countries reached 50% enrollment eight months early, with monthly accrual rates running 3–5x above plan through coordinated cross-functional execution.

• The Phase 2 Manufacturing Wall: The CMC Risk Hiding In Plain Sight

  Hidden gaps in process maturity and organizational alignment can derail development. Discover how to identify risks early and improve readiness for key milestones.

• Vertex On Building Risk Into Manufacturing Network Strategy

  Supply disruptions are becoming harder to predict. Explore practical strategies for continuity planning, supplier risk management, and network design to build lasting resilience.

• Clinical Trial Logistics: What Biopharma Needs To Prepare For Next

  Fragmented clinical trial logistics are slowing programs and increasing risk. Learn how coordinated planning and digital visibility are becoming competitive advantages in complex, global studies.

• Packaging And Labeling Support For A Global Cell Therapy Program

  Master complex cell therapy logistics with coordinated depots, purpose-built labeling, and temperature-controlled solutions that protect product integrity.

• Improving Clinical Trial Label Translation Through Centralized Reuse And Control

  Eliminate workflow inefficiencies and regulatory risk in global trials with a centralized translation framework and validated phrase library for consistent, cost-effective execution.